GlassScriptPhysician profile
Megan E Shannon
NPI 1790766327
$1,960.25
in general payments reported to CMS, 2019-2025
29 companies · $508 in 2025
The $508 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $172 · 2020: $125 · 2021: $227 · 2022: $471 · 2023: $301 · 2024: $157 · 2025: $508.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $888 · Entertainment: $77.59.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $888.06 |
| Entertainment | $77.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $271.54 | 2019-2025 | Grafix Pl, Stravix Pl, Stravix |
| Stryker Corporation | $220.99 | 2019-2023 | Gravity |
| Organogenesis INC. | $204.58 | 2020-2025 | Via Matrix, Novachor |
| Novus Surgical Solutions LLC | $185.60 | 2022 | |
| Bsn Medical INC | $133.52 | 2025 | |
| Musculoskeletal Transplant Foundation INC. | $121.01 | 2021-2023 | |
| Zimmer Biomet Holdings, INC. | $72.38 | 2020-2022 | |
| Alfasigma USA, INC. | $68.21 | 2020-2022 | |
| Horizon Therapeutics Plc | $67.23 | 2019-2021 | |
| Solventum Corporation | $59.13 | 2024 | Activ.A.C., Promogran Prisma |
| Treace Medical Concepts, INC. | $52.16 | 2025 | |
| Paragon 28, INC. | $49.76 | 2019-2023 | Portfolio |
| Next Science LLC | $45.11 | 2023-2025 | Blastx, Xperience, Surgx |
| Kerecis Limited | $43.03 | 2022 | |
| Kci USA, INC. | $42.25 | 2019-2022 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $42.13 | 2023 | Intellis Adaptivestim |
| Grt US Holding, INC. | $32.13 | 2020-2021 | |
| Bioventus LLC | $29.82 | 2021 | |
| Globus Medical, INC. | $26.91 | 2025 | Senza |
| Ibsa Pharma INC. | $22.44 | 2023 | Licart, Tirosint |
| Misonix INC | $21.60 | 2020 | |
| Integra Lifesciences Corporation | $21.35 | 2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Sanara Medtech INC. | $20.33 | 2022 | |
| Polynovo North America LLC | $20.18 | 2025 | Novosorb Btm |
| Vertex Pharmaceuticals Incorporated | $19.70 | 2025 | |
| Melinta Therapeutics, LLC | $18.83 | 2019 | |
| Abbott Laboratories | $17.80 | 2025 | Proclaim |
| Cashflow Solutions, LLC | $16.85 | 2023 | Pcd-52 737a (US) White, Pcd-51 731a (US) - White, Lympha Press Optimal Plus(US) Bt |
| Kowa Pharmaceuticals America, INC. | $13.68 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Megan Shannon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.